Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

After about 20 years of research and teaching as a faculty member at the University of Kansas and University of Minnesota, Dr. Sunil David founded ViroVax, LLC in 2019 in Lawrence, KS. ViroVax is a biotechnology company focused on research and development of vaccines, adjuvants, and therapeutics to protect and treat people from infectious diseases, including Zika, West Nile, Dengue, and SARS-CoV-2.

List your booth number for exhibitions, ask us